Correction to: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis.
Breast Cancer Res
; 22(1): 28, 2020 03 12.
Article
in En
| MEDLINE
| ID: mdl-32164744
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Diagnostic_studies
/
Prognostic_studies
Language:
En
Journal:
Breast Cancer Res
Journal subject:
NEOPLASIAS
Year:
2020
Type:
Article
Affiliation country:
Israel